Process for producing infant formula products and acidic dairy products from milk

Patent metadata

Field	Value
Publication number	US-11116233-B2
Application number	US-201716324068-A
Country	US
Kind code	B2
Filing date	Aug 8, 2017
Priority date	Aug 8, 2016
Publication date	Sep 14, 2021
Grant date	Sep 14, 2021

Abstract

The invention pertains to a process for simultaneous producing an infant formula product and an acidic dairy product from defatted animal milk, comprising (a) processing the milk into a casein stream, a whey protein stream and a lactose stream, by: (i) subjecting the defatted animal milk to a filtration step over a microfiltration membrane capable of retaining bacteria and permeating milk proteins, to provide a debacterialized milk as permeate; (ii) subjecting the permeate originating from step (i) to a filtration step over a microfiltration membrane capable of retaining casein and permeating whey proteins, to provide a casein stream as retentate and a permeate comprising whey protein; (iii) fractionating the permeate originating from step (ii) into a whey protein stream and a lactose stream; (b) combining part of the casein stream, at least part of the whey protein stream originating from step (a) and a lactose source to obtain a recombined stream, wherein the lactose source comprises acid whey; (c) using the recombined stream originating from step (b) in the manufacture of the infant formula product; (d) using part of the casein stream originating from step (a) in the manufacture of the acidic dairy product. The invention further concerns the infant formula product obtainable by step (c) of the process according to the invention, and to the acidic dairy product obtainable by step (d) of the process according to the invention.

First claim

The invention claimed is:

1. A process for producing an infant formula product and an acidic dairy product from defatted animal milk, comprising:
(a) processing the defatted animal milk into a casein stream, a whey protein stream and a lactose stream, by:
(i) subjecting the defatted animal milk to a filtration step over a microfiltration membrane capable of retaining bacteria and permeating milk proteins, to provide a debacterialized milk as permeate;
(ii) subjecting the permeate originating from step (i) to a filtration step over a microfiltration membrane capable of retaining casein and permeating whey proteins, to provide a casein stream as retentate and a permeate comprising whey protein;
(iii) fractionating the permeate originating from step (ii) into a whey protein stream and a lactose stream;

(b) combining part of the casein stream, at least part of the whey protein stream originating from step (a) and a lactose source to obtain a recombined stream, wherein the lactose source comprises acid whey;
(c) using the recombined stream originating from step (b) in the manufacture of the infant formula product;
(d) using part of the casein stream originating from step (a) in the manufacture of the acidic dairy product.

2. The process according to claim 1 , wherein the acid whey is obtained as a liquid stream from a separation step during the manufacture of an acidic dairy product.

3. The process according to claim 1 , wherein the acid whey is subjected to demineralization prior to being used as lactose source in step (b).

4. The process according to claim 3 , wherein the demineralization comprises at least one of salt precipitation, electrodialysis, lactose crystallization and ion exchange.

5. The process according to claim 3 , wherein the acid whey and at least part of the lactose stream originating from step (a) are combined and subsequently subjected to the demineralization prior to being used as lactose source in step (b).

6. The process according to claim 1 , wherein the combining of step (b) is done such that the whey protein to casein weight ratio in the recombined stream is in the range of 90:10 to 40:60.

7. The process according to claim 1 , wherein step (iii) is performed by ultrafiltration.

8. The process according to claim 7 , wherein the ultrafiltration step operates at a volume concentration factor in the range of 20-200.

9. The process according to claim 1 , wherein the manufacturing of step (c) includes at least one of drying, concentrating, supplementing with vitamins, minerals, lipids and/or dietary fibres and packaging.

10. The process according to claim 1 , wherein the defatted animal milk is the sole protein source for the infant formula product.

11. The process according to claim 10 , wherein the defatted animal milk is the sole protein source for the both infant formula product and the acidic dairy product.

12. The process according to claim 4 , wherein the demineralization is in combination with nanofiltration.

Assignees

• Gervais Danone Sa
• Nutricia Nv

Inventors

• David Franck
• Queguiner Claire
• Schmitt Laurent
• Hols Gerrit
• Tobin John
• Moonen Raoul Charles Johan
• Van Eijk-Van Boxtel Evelien Louise
• Abrahamse Evan

Classifications

• A23C9/1427

  by dialysis, reverse osmosis or hyperfiltration, e.g. for concentrating or desalting · CPC title

• A23C2210/252

  Separating a milk product in at least two fractions followed by treatment of at least one of the fractions and remixing at least part of the two fractions · CPC title

• A23C9/1512 Primary

  containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate · CPC title

• A23C9/20

  Dietetic milk products not covered by groups A23C9/12 - A23C9/18 · CPC title

• A23C2210/206

  Membrane filtration of a permeate obtained by ultrafiltration, nanofiltration or microfiltration · CPC title